Primary & Booster Immunogenicity Study of GSK Biologicals' Hib-MenC Versus a Licensed Men-C Vaccine

Conditions:   Haemophilus Influenzae Type b;   Neisseria MeningitidisIntervention:   Biological: Haemophilus influenzae type b- and meningococcal (vaccine)Sponsor:   GlaxoSmithKlineCompleted - verified November 2011
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials